Tables 1–3 show the top 10 subsidised drugs for the year July 2014 – June 2015. The figures are based on PBS and RPBS prescriptions from the date of supply, and do not include private prescriptions or prescriptions under the co-payment.
Table 1 - Top 10 drugs by DDD/1000 pop/day *
Drug
DDD/1000 pop/day
1. atorvastatin
54.65
2. rosuvastatin
39.47
3. paracetamol
34.14
4. perindopril
33.80
5. amlodipine
30.08
6. irbesartan
27.33
7. esomeprazole
25.27
8. candesartan
23.41
9. ramipril
21.62
10. telmisartan
18.84
Table 2 Top 10 drugs by prescription counts
Drug
Prescriptions
1. atorvastatin
7 787 189
2. esomeprazole
7 170 908
3. rosuvastatin
7 070 240
4. paracetamol
6 446 680
5. pantoprazole
4 489 551
6. perindopril
4 015 432
7. metformin
3 589 937
8. fluticasone and salmeterol
3 147 115
9. irbesartan
2 992 442
10. salbutamol
2 976 106
Table 3 Top 10 drugs by cost to government
Drug
Cost to government (A$)
DDD/1000 pop/day *
Prescriptions
1. adalimumab
311 616 305
0.57
176 062
2. rosuvastatin
206 589 091
39.47
7 070 240
3. aflibercept
192 839 767
†
123 123
4. ranibizumab
179 612 417
†
116 311
5. fluticasone and salmeterol
175 215 964
†
3 147 115
6. esomeprazole
174 179 985
25.27
7 170 908
7. etanercept
164 075 133
0.31
93 629
8. rituximab
156 563 805
†
46 763
9. insulin glargine
142 760 966
7.45
347 652
10. fingolimod
134 752 870
0.19
58 858
* DDD/thousand population/day is a more useful measure of drug utilisation than prescription counts. It shows how many people in every thousand Australians are taking the standard dose of a drug every day. DDD includes use in combination products. The calcuation is based on ABS 3101.0 – Australian Demographic Statistics for June 2014 (as at December 2014).
† The World Health Organization has not allocated a DDD for this drug.
Reasonable care is taken to provide accurate information at the time of creation. This information is not intended as a substitute for medical advice and should not be exclusively relied on to manage or diagnose a medical condition. NPS MedicineWise disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer. This website uses cookies. Read our privacy policy.